Professor of Medicine, USC School of Medicine
Hematology
Dr. Alexandra M. Levine, MD
|
|
Give Review
Dr. Alexandra M. Levine practices Hematology. She went to medical school at Keck School of Medicine of USC. Keck School of Medicine of USC has a rank of 31 in research and a 72 in primary care She received 1 awards: "Super Doctor". Alexandra M. Levine is a published MD as well. She has 83 publications published. The latest was: Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test. Alexandra Levine accepts Medicare.
Publications
- Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
- Risk of Breast Cancer with HIV-Using CXCR4 Defined by V3-Loop Sequencing.
- Longitudinal Trends in Sexual Behaviors with Advancing Age and Menopause Among Women With and Without HIV-1 Infection.
- Long-term cumulative detection of human papillomavirus among HIV seropositive women.
- Genital Tract HIV RNA Levels and Their Associations with Human Papillomavirus Infection and Risk of Cervical Pre-Cancer.
- The Relation of Plasmacytoid Dendritic Cells (pDCs) and Regulatory T-Cells (Tregs) with HPV Persistence in HIV-Infected and HIV-Uninfected Women.
- An effective reinduction regimen for first relapse of adult acute lymphoblastic leukemia.
- INCREASE IN SINGLE-TABLET REGIMEN USE AND ASSOCIATED IMPROVEMENTS IN ADHERENCE-RELATED OUTCOMES IN HIV-INFECTED WOMEN.
- Serum biomarkers of Immune activation and subsequent risk of non-Hodgkin B cell lymphoma among HIV-infected women.
- Changing patterns of anal canal carcinoma in the United States.
- Pegylated liposomal doxorubicin, rituximab, cyclophosphamide, vincristine, and prednisone in AIDS-related Lymphoma: AIDS Malignancy Consortium Study 047.
- Interleukin 10 responses are associated with sustained CD4 T-cell counts in treated HIV infection.
- Correlating Knowledge of Cervical Cancer Prevention and Human Papillomavirus With Compliance After Colposcopy Referral.
- Insomnia Symptoms and HIV Infection among Participants in the Women's Interagency HIV Study.
- Cervicovaginal HPV infection before and after hysterectomy: Evidence of different tissue tropism for oncogenic and non-oncogenic HPV types in a cohort of HIV-positive ...
- Effect of stress and depression on the frequency of squamous intraepithelial lesions.
- Relationship between complementary/alternative treatment use and illicit drug use among a cohort of women with, or at risk for, HIV infection.
- HIV-associated Lymphoma.
- Knowledge of cervical cancer prevention and human papillomavirus among women with HIV.
- HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study.
- Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-p...
- Marijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative women.
- Marginal and mixed-effects models in the analysis of human papillomavirus natural history data.
- Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).
- Histologic correlates of glandular abnormalities in cervical cytology among women with human immunodeficiency virus.
- Stem cell transplantation in AIDS-Lymphoma.
- Trends in mortality and causes of death among women with HIV in the United States: a 10-year study.
- Effects of chemotherapy in AIDS-associated non-Hodgkin's Lymphoma on Kaposi's sarcoma herpesvirus DNA in blood.
- Long-term incidence of cervical cancer in women with human immunodeficiency virus.
- Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.
- Management of AIDS-related Lymphoma.
- Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
- Association of cells with natural killer (NK) and NKT immunophenotype with incident cancers in HIV-infected women.
- Insulin-like growth factor axis and oncogenic human papillomavirus natural history.
- Combination treatment approaches and novel therapies for Lymphoma.
- Correlates of CD4+ and CD8+ lymphocyte counts in high-risk immunodeficiency virus (HIV)-seronegative women enrolled in the women's interagency HIV study (WIHS).
- Pharmacodynamics and safety of intravenous pegaspargase during remission induction in adults aged 55 years or younger with newly diagnosed acute lymphoblastic leukemia.
- Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV.
- Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.
- Monoclonal gammopathy associated with HIV infection.
- Progressive prothrombotic state in women with advancing HIV Disease.
- Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymp...
- Effects of HIV infection and its treatment on self-reported menstrual abnormalities in women.
- AIDS-related Lymphoma.
- Phase I study of antisense oligonucleotide against vascular endothelial growth factor: decrease in plasma vascular endothelial growth factor with potential clinical ef...
- Serological detection of human papillomavirus type 16 infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women.
- Marginal zone Lymphoma.
- Neutropenia in human immunodeficiency virus infection: data from the women's interagency HIV study.
- Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6.
- Prognostic factors in HIV-related diffuse large-cell Lymphoma: before versus after highly active antiretroviral therapy.
- Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin Lymphoma: AIDS-...
- Non-AIDS-defining cancers and HIV infection.
- Recent advances in acquired immunodeficiency syndrome (AIDS)-related Lymphoma.
- AIDS-related Burkitt''s Lymphoma versus diffuse large-cell Lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in ...
- Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
- Effects of bacterial vaginosis and other genital infections on the natural history of human papillomavirus infection in HIV-1-infected and high-risk HIV-1-uninfected w...
- Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
- Weekly docetaxel is safe and effective in the treatment of advanced-stage acquired immunodeficiency syndrome-related Kaposi sarcoma.
- Impact of highly active antiretroviral therapy on Anemia and relationship between Anemia and survival in a large cohort of HIV-infected women: Women's Interagency HIV ...
- Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection.
- T-cell Lymphoma in HIV-infected patients.
- Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes.
- Making dendritic cells from the inside out: lentiviral vector-mediated gene delivery of granulocyte-macrophage colony-stimulating factor and interleukin 4 into CD14+ m...
- Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women.
- Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hod...
- Medically eligible women who do not use HAART: the importance of abuse, drug use, and race.
- Effect of antiretroviral therapy on the incidence of genital warts and vulvar neoplasia among women with the human immunodeficiency virus.
- Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's Lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response.
- Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes.
- HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance.
- Treatment of AIDS related non-Hodgkin's Lymphoma with combination mitoguazone dihydrochloride and low dose CHOP chemotherapy: results of a phase II study.
- Treatment of HCV-related mantle-cell Lymphoma with ribavirin and pegylated interferon Alfa.
- Human papillomavirus type 16 and Immune status in human immunodeficiency virus-seropositive women.
- The use of lentiviral vectors in gene therapy of leukemia: combinatorial gene delivery of immunomodulators into leukemia cells by state-of-the-art vectors.
- Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.
- Establishment of B-cell Lymphoma cell lines persistently infected with hepatitis C virus in vivo and in vitro: the apoptotic effects of virus infection.
- Anemia in the setting of cancer and human immunodeficiency virus.
- Human immunodeficiency virus hematology.
- Challenges in the management of Burkitt's Lymphoma.
- Characteristics of indolent non-Hodgkin Lymphoma in patients with type 1 human immunodeficiency virus infection.
- Use of mammographic screening by HIV-infected women in the Women's Interagency HIV Study (WIHS).
- Evaluation and management of HIV-infected women.
Schools
University Of Southern California Keck School Of Medicine
LA CountyUSC Medical Center
Emory University School Of Medicine
Conditions Treated
- Anemia
- Coagulation Disorders (incl. Hemophilia)
- Hodgkin's Disease
- Immune Thrombocytopenic Purpura (ITP)
- View All
Doctors Specialties
- Hematology
Accepted Insurances
Awards
- Super Doctor
Education
-
University of Southern California - LAC+USC Medical Center -
Keck School of Medicine of USC
Hospital
-
Keck Hospital of USC -
City of Hope's Helford Clinical Research Hospital
Drug Facts
| NPI NUMBER | 1356371967 | |
| NPPES Provider LastName | LEVINE | |
| NPPES Provider FirstName | ALEXANDRA | |
| NPPES Provider ZIPCode | 910103012 | |
| NPPES Provider State | CA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 908.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 25.0 | |
| Percent Opioid Claims | 2.75 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356371967 |
| Last Name Of The Provider | LEVINE |
| First Name Of The Provider | ALEXANDRA |
| View All |
Similar Doctors
|
|
Dr. Matthew G. Mei, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nitya A. Nathwani, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Joseph C. Alvarnas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samer Khaled, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Rose Hiu, PA-C |